CHARACTERISTICS OF BONE MARROW PROGENITOR CELLS AS AN CRITERION FOR EVALUATING INDIVIDUAL RESPONSE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA TO THERAPY WITH TYROSINE KINASE INHIBITOR

Diachenko M., Zhaleiko I., Dyagil I., Perekhrestenko T., Bilko N.